Shanghai Municipal Hospital of Traditional Chinese Medicine
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 2013-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.wsjsw.gov.cn/wsj/
Clinical Trials
74
Active:0
Completed:5
Trial Phases
4 Phases
Phase 1:42
Phase 2:1
Phase 4:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (73 trials with phase data)• Click on a phase to view related trials
Phase 1
42 (57.5%)Not Applicable
28 (38.4%)Phase 4
2 (2.7%)Phase 2
1 (1.4%)Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer
Not Applicable
Not yet recruiting
- Conditions
- Cancer Symptom ClustersCancer
- Interventions
- Drug: Compound Ciwujia GranulesDrug: Placebo granulesCombination Product: Standard treatment protocol for ovarian cancer combined with psychological intervention.
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-29
- Target Recruit Count
- 316
- Registration Number
- NCT07050563
A Prospective Multi-Center Real-World Study of Ciwujia Capsules in the Treatment of Cancer-Related Insomnia
Not yet recruiting
- Conditions
- InsomniaCancerCancer Related Insomnia
- Interventions
- Drug: Ciwujia capsules
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-08
- Target Recruit Count
- 3000
- Registration Number
- NCT07050121
Electroacupuncture on Treating Cancer-related Depression
Not Applicable
Not yet recruiting
- Conditions
- DepressionCancer
- First Posted Date
- 2025-06-04
- Last Posted Date
- 2025-06-24
- Target Recruit Count
- 86
- Registration Number
- NCT07003763
A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver Disease
Phase 2
Completed
- Conditions
- Hepatic SteatosisSymptoms and Signs
- Interventions
- Drug: Chazhu Xiaozhi decoctionDrug: Control placebo
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2025-04-03
- Target Recruit Count
- 70
- Registration Number
- NCT06442137
- Locations
- 🇨🇳
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, Shanghai, China
LCMD for Type 2 Diabetes Remission: Evaluation of Effectiveness and Exploration of Individual Differences
Not Applicable
Not yet recruiting
- Conditions
- Type 2 Diabetes Mellitus in ObeseType 2 Diabetes
- First Posted Date
- 2024-06-04
- Last Posted Date
- 2024-06-04
- Target Recruit Count
- 170
- Registration Number
- NCT06442150
- Locations
- 🇨🇳
Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai, Shanghai, China
- Prev
- 1
- 2
- 3
- Next
News
No news found